The hypericom perforatom effect on anxiety
Phase 3
- Conditions
- anxiety.Generalized anxiety disorder
- Registration Number
- IRCT201109277651N1
- Lead Sponsor
- Tehran Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
who suffered anxiety; they were not pregnant or breast feeding. Furthermore they was not taking hormonal, anti-anxiety or anti depression drugs. Exclusion criteria: drug allergy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety. Timepoint: Before and After the search. Method of measurement: spilberger (questionnaire).
- Secondary Outcome Measures
Name Time Method